DOUTOR・NICHIRES Holdings Co.,Ltd. (3087) · TargetRestated
Growth in the Ordinary Profit Margin on Sales
First written in FY2018. 3 of 4 entries say "Restated". Latest entry: FY2026.
4entries
9years
0from disclosures
How it moved
Same theme, other companies
Stabilization and Improvement of Ordinary Profit MarginA theme 36 companies write about · 0 as a headwind · 36 as a tailwind
The whole theme swung hardest in 2020: 8 of 29 companies on the "Worse" side.
7 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 36 companies compared. The sentences above are computed from all 36.Full recordFilings, disclosures and news, newest first
- FY2026RestatedAnnual report
「The company has set growth in its ordinary profit margin on sales as a management metric target.」
The company continues to set growth in its ordinary profit margin on sales as a management metric target. - FY2025RestatedAnnual report
「The company has set growth in its ordinary profit margin on sales as a management metric target.」
The company continues to set growth in its ordinary profit margin on sales as a management metric target. - FY2019RestatedAnnual report
「The company has set growth in its ordinary profit margin on sales as a management metric target.」
The company continues to set growth in its ordinary profit margin on sales as a management metric target. No specific numerical target or deadline is provided. - FY2018First statedAnnual report
「The company has set growth in its ordinary profit margin on sales as a management metric target.」
For the first time, the group independently specifies growth in its ordinary profit margin on sales as a management metric target. No specific numerical target or deadline is provided.